{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:32:20Z","timestamp":1787509940185,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.pnpbp.2012.10.025","type":"journal-article","created":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T17:45:17Z","timestamp":1352396717000},"page":"353-363","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Clozapine regulation of p90RSK and c-Fos signaling via the ErbB1-ERK pathway is distinct from olanzapine and haloperidol in mouse cortex and striatum"],"prefix":"10.1016","volume":"40","author":[{"given":"Avril","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Malcolm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Sundram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2012.10.025_bb0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1196\/annals.1397.080","article-title":"Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefrontal cortex in schizophrenia and in unipolar depression","volume":"1096","author":"Bertram","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"22","key":"10.1016\/j.pnpbp.2012.10.025_bb0010","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1523\/JNEUROSCI.1039-08.2008","article-title":"Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol","volume":"28","author":"Bertran-Gonzalez","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2012.10.025_bb0015","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1124\/jpet.106.110684","article-title":"Habituation deficits induced by metabotropic glutamate receptors 2\/3 receptor blockade in mice: reversal by antipsychotic drugs","volume":"320","author":"Bespalov","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2012.10.025_bb0020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.biopsych.2004.12.002","article-title":"Clozapine and the mitogen-activated protein kinase signal transduction pathway: implications for antipsychotic actions","volume":"57","author":"Browning","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.10.025_bb0025","first-page":"37","article-title":"Identification of the neural systems subserving the actions of clozapine: clues from immediate-early gene expression","volume":"55","author":"Deutch","year":"1994","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.10.025_bb0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0306-4522(95)00357-6","article-title":"The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization","volume":"70","author":"Deutch","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2012.10.025_bb0035","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bcp.2006.01.020","article-title":"Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinase","volume":"71","author":"Ellis","year":"2006","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.pnpbp.2012.10.025_bb0040","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/sj.mp.4002135","article-title":"The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement","volume":"14","author":"Engel","year":"2009","journal-title":"Mol Psychiatry"},{"issue":"27","key":"10.1016\/j.pnpbp.2012.10.025_bb0045","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1523\/JNEUROSCI.23-27-09116.2003","article-title":"Impaired long-term memory and NR2A-type NMDA receptor-dependent synaptic plasticity in mice lacking c-Fos in the CNS","volume":"23","author":"Fleischmann","year":"2003","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2012.10.025_bb0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0303-7207(99)00061-1","article-title":"Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction","volume":"151","author":"Frodin","year":"1999","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.10.025_bb0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.mp.4001138","article-title":"Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development","volume":"8","author":"Futamura","year":"2003","journal-title":"Mol Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2012.10.025_bb0060","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nm1418","article-title":"Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia","volume":"12","author":"Hahn","year":"2006","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.10.025_bb0065","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biopsych.2005.11.002","article-title":"Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology","volume":"60","author":"Harrison","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2012.10.025_bb0070","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/dneu.20655","article-title":"Normal dendrite growth in Drosophila motor neurons requires the AP-1 transcription factor","volume":"68","author":"Hartwig","year":"2008","journal-title":"Dev Neurobiol"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.10.025_bb0075","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.neuroscience.2010.04.018","article-title":"Enhanced c-Fos expression in superior colliculus, paraventricular thalamus and septum during learning of cue-reward association","volume":"168","author":"Igelstrom","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2012.10.025_bb0080","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine D(2) receptor explain the action of atypical antipsychotics?: A new hypothesis","volume":"158","author":"Kapur","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.10.025_bb0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/mp.2010.10","article-title":"Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia","volume":"16","author":"Kato","year":"2011","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2012.10.025_bb0090","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1017\/S1461145707008292","article-title":"Haloperidol regulates the phosphorylation level of the MEK-ERK-p90RSK signal pathway via protein phosphatase 2A in the rat frontal cortex","volume":"11","author":"Kim","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.10.025_bb0095","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0893-133X(02)00289-0","article-title":"Chronic antipsychotic drug treatment induces long-lasting expression of fos and jun family genes and activator protein 1 complex in the rat prefrontal cortex","volume":"27","author":"Kontkanen","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"9657","key":"10.1016\/j.pnpbp.2012.10.025_bb0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2012.10.025_bb0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2008.08.020","article-title":"Delta-9-tetrahydrocannabinol differently affects striatal c-Fos expression following haloperidol or clozapine administration","volume":"598","author":"Marchese","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.10.025_bb0110","doi-asserted-by":"crossref","first-page":"13656","DOI":"10.1073\/pnas.0803522105","article-title":"Antagonism of dopamine D2 receptor\/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics","volume":"105","author":"Masri","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.pnpbp.2012.10.025_bb0115","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/appi.ajp.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"16","author":"McEvoy","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.10.025_bb0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.10.025_bb0125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12031-009-9188-5","article-title":"Clozapine-induced ERK1 and ERK2 signaling in prefrontal cortex is mediated by the EGF receptor","volume":"39","author":"Pereira","year":"2009","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.pnpbp.2012.10.025_bb0130","first-page":"1","article-title":"Clozapine induction of ERK1\/2 cell signaling via the EGF receptor in mouse prefrontal cortex and striatum is distinct from other antipsychotic drugs","volume":"27","author":"Pereira","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.10.025_bb0135","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1471-4159.2003.01851.x","article-title":"Opposite regulation by typical and atypical anti-psychotics of ERK1\/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum","volume":"86","author":"Pozzi","year":"2003","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.10.025_bb0140","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0306-4522(92)90054-6","article-title":"Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine","volume":"46","author":"Robertson","year":"1992","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.10.025_bb0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0893-133X(95)00196-K","article-title":"Effects of olanzapine on regional c-Fos expression in rat forebrain","volume":"14","author":"Robertson","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.10.025_bb0150","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0022-3565(25)23800-9","article-title":"Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity","volume":"271","author":"Robertson","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.10.025_bb0155","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1006\/mcne.2002.1188","article-title":"Phosphorylation of hippocampal Erk-1\/2, Elk-1, and p90-Rsk-1 during contextual fear conditioning: interactions between Erk-1\/2 and Elk-1","volume":"21","author":"Sananbenesi","year":"2002","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.10.025_bb0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuint.2011.10.018","volume":"60","author":"Sarantis","year":"2012","journal-title":"Neurochem Int"},{"issue":"21","key":"10.1016\/j.pnpbp.2012.10.025_bb0165","doi-asserted-by":"crossref","first-page":"8814","DOI":"10.1523\/JNEUROSCI.18-21-08814.1998","article-title":"Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation","volume":"18","author":"Sgambato","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2012.10.025_bb0170","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00213-006-0595-9","article-title":"Neonatal exposure to epidermal growth factor induces dopamine D2-like receptor supersensitivity in adult sensorimotor gating","volume":"191","author":"Sotoyama","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.10.025_bb0175","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.conb.2004.04.001","article-title":"Mitogen-activated protein kinases in synaptic plasticity and memory","volume":"14","author":"Sweatt","year":"2004","journal-title":"Curr Opin Neurobiol"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2012.10.025_bb0180","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2007.11.033","article-title":"World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia","volume":"100","author":"Tandon","year":"2008","journal-title":"Schizophr Res"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2012.10.025_bb0185","first-page":"83","article-title":"Mitogen-activated protein kinase\/extracellular signal-regulated kinase induced gene regulation in brain: a molecular substrate for learning and memory?","volume":"23","author":"Valjent","year":"2001","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.10.025_bb0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neures.2006.09.002","article-title":"Chronic high-dose haloperidol has qualitatively similar effects to risperidone and clozapine on immediate-early gene and tyrosine hydroxylase expression in the rat locus coeruleus but not medial prefrontal cortex","volume":"57","author":"Verma","year":"2007","journal-title":"Neurosci Res"},{"issue":"8","key":"10.1016\/j.pnpbp.2012.10.025_bb0195","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0166-2236(88)90060-4","article-title":"Schizophrenia and the frontal lobe","volume":"11","author":"Weinberger","year":"1988","journal-title":"Trends Neurosci"},{"issue":"18","key":"10.1016\/j.pnpbp.2012.10.025_bb0200","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1097\/00001756-200312190-00028","article-title":"Effects of haloperidol and clozapine on Fos expression in the primate striatum","volume":"14","author":"Wirtshafter","year":"2003","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.10.025_bb0205","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S146114570500516X","article-title":"A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia","volume":"8","author":"Woodward","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"issue":"5277","key":"10.1016\/j.pnpbp.2012.10.025_bb0210","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.273.5277.959","article-title":"Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase","volume":"273","author":"Xing","year":"1996","journal-title":"Science"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584612002813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584612002813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T10:00:27Z","timestamp":1745143227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584612002813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":42,"alternative-id":["S0278584612002813"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2012.10.025","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}